POCT

This market will boom

The turnover in POCT diagnostics will continue to increase substantially according to participants in an ‘In Vitro Diagnostic Products’ meeting held in Toronto, Canada last October. Sponsored by the German Institute for Standardisation, the event included participation by the DIN Standards Committee Medicine (NAMed; NA 063) and the Working Committee on Point of Care Testing (POCT) (NA 063-03-11 AA).

Photo: This market will boom
Source: Becton Dickinson
Photo: This market will boom
Source: Becton Dickinson

In 2013 in the USA, turnover for products used to diagnose glucose levels, infections, heart disease and cancers, to name the most important conditions, was around US$25.2 billion. The forecast for 2018 is estimated at US$27.5 billion, an increase of around 9.3%.

Robert L Michel (Editor-in-Chief of The Dark Report) spoke of the particularly poignant diabetes occurrence in the US. 29.1 million Americans are diabetics, i.e. roughly 9.3% of the population. 21 million people were found to have diabetes following a specific diagnosis. 8.1 million people had no diagnosis. 75 million people are estimated to have pre-diabetic symptoms already.

The number of POCT tests and their applications is growing exponentially. Many experts in Toronto particularly saw technological progress leading to distinct changes. Classic areas of application, such as chemistry, toxicology, haematCology and microbiology, are using more and specific test proceduoeres for Point-of-Care. For example, the latest trends include additional modules for smartphones, such as those used for glucose and thyroid stimulating hormone (TSH) diagnosis. The number of Point-of-Care DNA tests being used, some highly complex, is also increasing. Another interesting trend revolves around ‘smart’ nappies with an integrated, specific urine test for babies and other patients.

Based on examples from Australia and Canada (more specifically from the Ontario region) diagnostic networks to treat HIV, and also cardiac disease, were introduced at the event. This emphasised the clear advantage of comprehensive POCT diagnostics, particularly regarding their analytical quality.

Ana Stankovic, Vice President of Becton Dickinson (BD) opened the event with a detailed overview of POC diagnostics workflow, emphasising the issue of potential error sources and relevance of timing for these tests.

In conclusion, the importance and usability of POC tests can no longer be questioned. Frequently, they are on a par with tests used in conventional laboratory diagnostics, whilst clearly easier to use – and faster. Provided the critical points, such as error sources, are given enough consideration, this form of testing will continue to boom and grow.

27.04.2015

Read all latest stories

Related articles

Photo

Automated tasks

Fast, efficient, cheaper microbiology diagnostics

A fully automated clinical microbiology laboratory system went into service at Heidelberg University Hospital this April. Produced by medical technology firm BD Life Science, this first installation…

Qualification

Diabetes-Nanny

About 25,000 German children are diabetic, and numbers are increasing rapidly. Specialists in childhood diabetes gathered at a meeting held by the Dianino Foundation during the 41st Annual Meeting of…

Photo

Mobile cMyC analysis

The future POCT heart attack test

Experts report that a new blood test to diagnose heart attacks could be carried out on a hand-held device in the not-too-distant future. The test, devised by a team at Kings College London, uses…

Related products

BD/QIAGEN PAXgene Blood ccfDNA Tube

Liquid Biopsy

BD/QIAGEN PAXgene Blood ccfDNA Tube

BD – Becton Dickinson
BD Vacutainer – Barricor Blood Collection Tube

Clinical Chemistry

BD Vacutainer – Barricor Blood Collection Tube

BD – Becton Dickinson
BD Vacutainer UltraTouch Push Button Blood Collection Set

Blood Collection

BD Vacutainer UltraTouch Push Button Blood Collection Set

BD – Becton Dickinson
BD Vacutainer Urine Collection System

Urine Screening

BD Vacutainer Urine Collection System

BD – Becton Dickinson
BD Vacutainer Urine Tubes for Microbiology

Other

BD Vacutainer Urine Tubes for Microbiology

BD – Becton Dickinson